AR017760A1 - A TRANSDERMAL DOSAGE FORM THAT INCLUDES A NON-REDUCING ANDROGEN IN 5-ALFA - Google Patents
A TRANSDERMAL DOSAGE FORM THAT INCLUDES A NON-REDUCING ANDROGEN IN 5-ALFAInfo
- Publication number
- AR017760A1 AR017760A1 ARP980104736A AR017760A1 AR 017760 A1 AR017760 A1 AR 017760A1 AR P980104736 A ARP980104736 A AR P980104736A AR 017760 A1 AR017760 A1 AR 017760A1
- Authority
- AR
- Argentina
- Prior art keywords
- dosage form
- transdermal
- androgen
- alpha
- transdermal dosage
- Prior art date
Links
- 239000003098 androgen Substances 0.000 title abstract 4
- 239000006211 transdermal dosage form Substances 0.000 title abstract 4
- YSGQGNQWBLYHPE-CFUSNLFHSA-N (7r,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2[C@H](C)CC3=CC(=O)CC[C@@H]3[C@H]21 YSGQGNQWBLYHPE-CFUSNLFHSA-N 0.000 abstract 3
- 239000006071 cream Substances 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Una forma de dosificacion transdérmica que comprende una cantidad terapéuticamente efectiva de un androgeno no reducible en 5-alfa dispersa en un vehículotransdérmico aceptable farmacéuticamente aceptable. La forma de dosificacion transdérmica puedeser un unguento, una crema, un gel, un polvo, un parchetransdérmico, una locion, una solucion atomizadora o similares. El androgeno no reducible en 5-alfa preferido es un androgeno 7 alfa modificado y en particular7-alfa-metil-19-nortestosterona (MENT). Preferiblemente, la forma de dosificacion transdérmica incluye una cantidad entre 0,5 y 10 mg aproximadamente de MENTdispersa en el vehículo transdérmico farmacéuticamente aceptable.A transdermal dosage form comprising a therapeutically effective amount of a non-reducible 5-alpha androgen dispersed in a pharmaceutically acceptable acceptable transdermal carrier. The transdermal dosage form can be an ointment, a cream, a gel, a powder, a transdermal patch, a lotion, an atomizing solution or the like. The preferred non-reducible 5-alpha androgen is a modified 7-alpha androgen 7 and in particular 7-alpha-methyl-19-nortestosterone (MENT). Preferably, the transdermal dosage form includes an amount between about 0.5 and 10 mg of MENT dispersed in the pharmaceutically acceptable transdermal vehicle.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/154,287 US20020012694A1 (en) | 1997-09-17 | 1998-09-16 | Transdermal administration of ment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR017760A1 true AR017760A1 (en) | 2001-10-24 |
Family
ID=45606376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980104736 AR017760A1 (en) | 1998-09-16 | 1998-09-22 | A TRANSDERMAL DOSAGE FORM THAT INCLUDES A NON-REDUCING ANDROGEN IN 5-ALFA |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR017760A1 (en) |
-
1998
- 1998-09-22 AR ARP980104736 patent/AR017760A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA964873B (en) | Tricot-like pouch for the delivery of topical drugs and cosmetics. | |
| PL321898A1 (en) | Application of inorganic aerogles in pharmaceutics | |
| AU2003297260A1 (en) | Fast-disintegrating solid dosage forms being not friable and comprising pullulan | |
| NO931766L (en) | TOPICAL PREPARATIONS FOR TRANSDERMAL DELIVERY OF PRESERVANT MEDICINAL DERIVATIVES OF MORPHINE | |
| TW349024B (en) | Freeze-dried liposome delivery system for application of skin treatment agents | |
| AU3136897A (en) | Compositions, methods and devices for the transdermal delivery of drugs | |
| MXPA01003068A (en) | Pharmaceutical composition for the treatment of acute disorders. | |
| EP0993831A3 (en) | Compounds and compositions for delivering active agents | |
| AR002007A1 (en) | A THERAPEUTIC COMPOSITION OF TOPICAL APPLICATION CONTAINING AN ANTAGONIST OF SUBSTANCE P AND USE OF SUCH ANTAGONIST FOR THE PREPARATION OF SUCH COMPOSITION TO DECREASE AND / OR ELIMINATE AN IRRITATING SIDE EFFECT OF A PRODUCT CONTAINED IN IT. | |
| NZ504076A (en) | A topical formulation which induces a minimal systemic effect when applied to the skin, the topical formulation comprising an immunosuppressive macrolide selected from sirolimus, FK506 and SDZ ASM 981 and a permeation modulator for the treatment of a dermatological condition | |
| NL300258I2 (en) | Pharmaceutical composition for use in the treatment of. | |
| CA2338358A1 (en) | Compounds and compositions for delivering active agents | |
| PL329802A1 (en) | Derivatives of androstene | |
| PL353738A1 (en) | Composition containing an active substance, production and use thereof | |
| CA2271944A1 (en) | Formulation for electrically assisted delivery of lidocaine and epinephrine | |
| CA2339836A1 (en) | Active ingredient support in the form of a film | |
| WO2001045650A3 (en) | Cosmetic use of the residues from wine production | |
| PL348202A1 (en) | Pharmaceutically active composition and dispensing device | |
| AR011437A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MIGRANES AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT. | |
| IL118218A0 (en) | Terpenoidic derivatives and pharmaceutical compositions containing them | |
| ATE257374T1 (en) | AQUEOUS MEDICINAL PRODUCT CONTAINING AN ACTIVE COMPONENT THAT IS VERY POORLY SOLUBLE IN WATER | |
| AR017760A1 (en) | A TRANSDERMAL DOSAGE FORM THAT INCLUDES A NON-REDUCING ANDROGEN IN 5-ALFA | |
| AU3631500A (en) | N-adamant-1-yl-n'-(4-chlorobenzothiazol-2-yl) urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent | |
| AU3600199A (en) | A pharmaceutical composition containing ezrin mutated on tyrosine 353 | |
| HU9403736D0 (en) | Topical application composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |